Patent · US Expired

Bicyclic oligopeptides

US7101848B2 · kind B2 · utility

0Cited by

2References

7Claims

0Family size

Assignee

BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG · DE

Inventors

Olivier Potterat · Aesch, CH
Ruediger Streicher · Biberach, DE
Klaus Wagner · Warthausen, DE
Till Maurer · Munderkingen, DE
Juergen Mack · Biberach an der Riß, DE
Stefan Peters · Biberach an der Riß, DE

Key dates

Filing date	Jul 17, 2003
Grant date	Sep 5, 2006
Priority date	—
Expiry date	Apr 20, 2024

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a bicyclic oligopeptide or ester thereof having the capability to inhibit the glucagon receptor, comprised of:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.